top of page
Browse by category
Search


Positive results for Ascletis’ oral GLP-1ra ASC30
Ascletis Pharma has announced positive topline results from its US single ascending dose (SAD) study of ASC30 oral tablet in patients...


Jiangsu and Kailera report positive topline data for 8mg HRS9531 GLP-1/GIP
Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics have announced positive topline data from the 8mg dose of Hengrui Pharma’s Phase...


Fatty muscles increase the risk of CVD regardless of BMI
People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalised from a heart attack or heart...


Neurons that control the amount of MC4R affect how much the protein guards against obesity
Mutations in a gene called OTP cause obesity by controlling the output of another gene already targeted by an anti-obesity drug, a study...


Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease
The Lancet Commission on Clinical Obesity recommends a new, nuanced approach where measures of body fat - for example, waist...


Multi-layered omics analysis offers insight into biology and risk factors of childhood obesity
A cutting-edge molecular approach provides a detailed picture of the biological pathways associated with childhood obesity and metabolic...


Study finds persistent racial disparities and growing sex disparities of bariatric patients
There are persistent racial disparities and growing sex disparities between patients who discussed and received bariatric and metabolic...


Journal Watch 15/1/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


AUDACITY Trial: Low rate of serious adverse events supports favourable safety profile of the Allurion Balloon
Allurion Technologies has revealed topline results - from the AUDACITY Food & Drug Administration (FDA) pivotal trial evaluating the...


ReShape Lifesciences provides merger update with Vyome Therapeutics
ReShape Lifesciences and Vyome Therapeutics have provided an update on the definitive merger agreement under which ReShape and Vyome will...
Browse by tag






bottom of page
